Acurx Pharmaceuticals, Inc. (ACXP)

NASDAQ: ACXP · IEX Real-Time Price · USD
2.61
0.09 (3.69%)
At close: May 27, 2022 3:56 PM
2.21
-0.40 (-15.42%)
After-hours:May 27, 2022 7:30 PM EDT

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year202120202019
Selling, General & Admin
10.782.42.42
Research & Development
2.032.23.51
Operating Expenses
12.814.65.93
Operating Income
-12.81-4.6-5.93
Other Expense / Income
-0.0700
Pretax Income
-12.75-4.6-5.93
Net Income
-12.75-4.6-5.93
Net Income Common
-12.75-4.6-5.93
Shares Outstanding (Basic)
96-
Shares Outstanding (Diluted)
96-
Shares Change
37.88%--
EPS (Basic)
-1.49-0.74-
EPS (Diluted)
-1.49-0.74-
Free Cash Flow Per Share
-0.59-0.54-
EBITDA
-12.75-4.6-5.93
EBIT
-12.75-4.6-5.93
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).